These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 36763086)
21. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ PLoS One; 2013; 8(1):e54193. PubMed ID: 23349823 [TBL] [Abstract][Full Text] [Related]
22. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer. Tada Y; Yokomizo A; Shiota M; Tsunoda T; Plass C; Naito S Int J Oncol; 2011 Sep; 39(3):727-33. PubMed ID: 21617853 [TBL] [Abstract][Full Text] [Related]
23. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma. Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651 [TBL] [Abstract][Full Text] [Related]
24. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945 [TBL] [Abstract][Full Text] [Related]
25. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034 [TBL] [Abstract][Full Text] [Related]
26. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2. Zhang Y; Lin W; Jiang W; Wang Z Bioengineered; 2022 Apr; 13(4):9959-9972. PubMed ID: 35416122 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer. Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864 [TBL] [Abstract][Full Text] [Related]
29. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway. Yan G; Chang Z; Wang C; Gong Z; Xin H; Liu Z Dig Liver Dis; 2022 Jan; 54(1):125-135. PubMed ID: 34053876 [TBL] [Abstract][Full Text] [Related]
30. Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells. Sui Y; Hu W; Zhang W; Li D; Zhu H; You Q; Zhu R; Yi Q; Tang T; Gao L; Zhu S; Yang T Br J Cancer; 2021 Sep; 125(7):1003-1015. PubMed ID: 34247196 [TBL] [Abstract][Full Text] [Related]
31. The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer. Sellar GC; Watt KP; Li L; Nelkin BD; Rabiasz GJ; Porteous DJ; Smyth JF; Gabra H Int J Oncol; 2002 Nov; 21(5):929-33. PubMed ID: 12370737 [TBL] [Abstract][Full Text] [Related]
32. ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter. Hu M; Li H; Xie H; Fan M; Wang J; Zhang N; Ma J; Che S ACS Chem Neurosci; 2021 Apr; 12(7):1252-1261. PubMed ID: 33720698 [TBL] [Abstract][Full Text] [Related]
33. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin. Stubbert LJ; Smith JM; McKay BC BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425 [TBL] [Abstract][Full Text] [Related]
34. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957 [TBL] [Abstract][Full Text] [Related]
35. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1. Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783 [TBL] [Abstract][Full Text] [Related]
36. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1. Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664 [TBL] [Abstract][Full Text] [Related]
37. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer. Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029 [No Abstract] [Full Text] [Related]
38. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer. Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677 [TBL] [Abstract][Full Text] [Related]
39. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells. Li Y; Sun J; Gao S; Hu H; Xie P Gene; 2018 Jul; 663():9-16. PubMed ID: 29660518 [TBL] [Abstract][Full Text] [Related]
40. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]